메뉴 건너뛰기




Volumn 28, Issue 2, 2014, Pages 80-84

Corrigendum: Blood pressure targets in the treatment of high blood pressure: A reappraisal of the J-shaped phenomenon (Journal of Human Hypertension (2014) 28 (80-84) DOI: 10.1038/jhh.2013.78);Blood pressure targets in the treatment of high blood pressure: A reappraisal of the J-shaped phenomenon

Author keywords

Blood pressure treatment; J shaped phenomenon

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; INDAPAMIDE PLUS PERINDOPRIL; PERINDOPRIL; PLACEBO; RAMIPRIL; TRANDOLAPRIL PLUS VERAPAMIL;

EID: 84891850844     PISSN: 09509240     EISSN: 14765527     Source Type: Journal    
DOI: 10.1038/jhh.2013.110     Document Type: Erratum
Times cited : (12)

References (43)
  • 1
    • 0018166486 scopus 로고
    • Re-examination of some of the Framingham blood pressure data
    • Anderson TW. Re-examination of some of the Framingham blood pressure data. Lancet 1978; 2: 1139-1141.
    • (1978) Lancet , vol.2 , pp. 1139-1141
    • Anderson, T.W.1
  • 2
    • 0018772401 scopus 로고
    • Relation of reduction in pressure to first myocardial infarction in patients receiving treatment for severe hypertension
    • Stewart IM. Relation of reduction in pressure to first myocardial infarction in patients receiving treatment for severe hypertension. Lancet 1979; 1: 861-865.
    • (1979) Lancet , vol.1 , pp. 861-865
    • Stewart, I.M.1
  • 3
    • 0023122783 scopus 로고
    • Benefits and potential harm of lowering high blood pressure
    • Cruickshank JM, Thorp JM, Zacharias FJ. Benefits and potential harm of lowering high blood pressure. Lancet 1987; 1: 581-584.
    • (1987) Lancet , vol.1 , pp. 581-584
    • Cruickshank, J.M.1    Thorp, J.M.2    Zacharias, F.J.3
  • 5
    • 0028288303 scopus 로고
    • Control of blood pressure and risk of first acute myocardial infarction: Skaraborg hypertension project
    • Lindblad U, Rastam L, Ryden L, Ranstam J, Isacsson SO, Berglund G. Control of blood pressure and risk of first acute myocardial infarction: Skaraborg hypertension project. BMJ 1994; 308: 681-686.
    • (1994) BMJ , vol.308 , pp. 681-686
    • Lindblad, U.1    Rastam, L.2    Ryden, L.3    Ranstam, J.4    Isacsson, S.O.5    Berglund, G.6
  • 6
    • 0032854024 scopus 로고    scopus 로고
    • Hypotension in patients with coronary disease: Can profound hypotensive events cause myocardial ischaemic events?
    • Owens P, O'Brien E. Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Heart 1999; 82: 477-481.
    • (1999) Heart , vol.82 , pp. 477-481
    • Owens, P.1    O'brien, E.2
  • 7
    • 0032513878 scopus 로고    scopus 로고
    • Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: Principal results of the Hypertension Optimal Treatment (HOT) randomised trial
    • Hansson L, Zanchetti A, Carruthers SG, Dahlof B, Elmfeldt D, Julius S et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group. Lancet 1998; 351: 1755-1762.
    • (1998) HOT Study Group. Lancet , vol.351 , pp. 1755-1762
    • Hansson, L.1    Zanchetti, A.2    Carruthers, S.G.3    Dahlof, B.4    Elmfeldt, D.5    Julius, S.6
  • 8
    • 0033837878 scopus 로고    scopus 로고
    • Antihypertensive treatment and the J-curve
    • Cruickshank JM. Antihypertensive treatment and the J-curve. Cardiovasc Drugs Ther 2000; 14: 373-379.
    • (2000) Cardiovasc Drugs Ther , vol.14 , pp. 373-379
    • Cruickshank, J.M.1
  • 9
    • 0038460302 scopus 로고    scopus 로고
    • The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: The jnc 7 report
    • Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo Jr JL et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 Report. JAMA 2003; 289: 2560-2571.
    • (2003) JAMA , vol.289 , pp. 2560-2571
    • Chobanian, A.V.1    Bakris, G.L.2    Black, H.R.3    Cushman, W.C.4    Green, L.A.5    Izzo Jr., J.L.6
  • 12
    • 79956369107 scopus 로고    scopus 로고
    • Mixed messages on blood pressure goals
    • Chobanian AV. Mixed messages on blood pressure goals. Hypertension 2011; 57: 1039-1040.
    • (2011) Hypertension , vol.57 , pp. 1039-1040
    • Chobanian, A.V.1
  • 13
    • 84864289304 scopus 로고    scopus 로고
    • Optimal antihypertensive level for improvement of coronary microvascular dysfunction: The lower, the better?
    • Mizuno R, Fujimoto S, Saito Y, Okamoto Y. Optimal antihypertensive level for improvement of coronary microvascular dysfunction: the lower, the better? Hypertension 2012; 60: 326-332.
    • (2012) Hypertension , vol.60 , pp. 326-332
    • Mizuno, R.1    Fujimoto, S.2    Saito, Y.3    Okamoto, Y.4
  • 14
    • 0037079309 scopus 로고    scopus 로고
    • Age-specific relevance of usual blood pressure to vascular mortality: A meta-analysis of individual data for one million adults in 61 prospective studies
    • Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002; 360: 1903-1913.
    • (2002) Lancet , vol.360 , pp. 1903-1913
    • Lewington, S.1    Clarke, R.2    Qizilbash, N.3    Peto, R.4    Collins, R.5
  • 15
    • 84867666043 scopus 로고    scopus 로고
    • Proof of concept in cardiovascular risk: The paradoxical findings in blood pressure and lipid abnormalities
    • Fuchs FD, Fuchs SC, Moreira LB, Gus M. Proof of concept in cardiovascular risk: the paradoxical findings in blood pressure and lipid abnormalities. Vasc Health Risk Manag 2012; 8: 437-442.
    • (2012) Vasc Health Risk Manag , vol.8 , pp. 437-442
    • Fuchs, F.D.1    Fuchs, S.C.2    Moreira, L.B.3    Gus, M.4
  • 16
    • 67650082354 scopus 로고    scopus 로고
    • Use of blood pressure lowering drugs in the prevention of cardiovascular disease: Meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies
    • Law MR, Morris JK, Wald NJ. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ 2009; 338: B1665.
    • (2009) BMJ , vol.338
    • Law, M.R.1    Morris, J.K.2    Wald, N.J.3
  • 18
    • 0024602089 scopus 로고
    • Paradoxical survival of elderly men with high blood pressure
    • Langer RD, Ganiats TG, Barrett-Connor E. Paradoxical survival of elderly men with high blood pressure. BMJ 1989; 298: 1356-1358.
    • (1989) BMJ , vol.298 , pp. 1356-1358
    • Langer, R.D.1    Ganiats, T.G.2    Barrett-Connor, E.3
  • 19
    • 0032737077 scopus 로고    scopus 로고
    • A U-shaped association between home systolic blood pressure and four-year mortality in community-dwelling older men
    • Okumiya K, Matsubayashi K, Wada T, Fujisawa M, Osaki Y, Doi Y et al. A U-shaped association between home systolic blood pressure and four-year mortality in community-dwelling older men. J Am Geriatr Soc 1999; 47: 1415-1421.
    • (1999) J Am Geriatr Soc , vol.47 , pp. 1415-1421
    • Okumiya, K.1    Matsubayashi, K.2    Wada, T.3    Fujisawa, M.4    Osaki, Y.5    Doi, Y.6
  • 21
    • 0036153502 scopus 로고    scopus 로고
    • Development of predictive models for long-term cardiovascular risk associated with systolic and diastolic blood pressure
    • Glynn RJ, L'Italien GJ, Sesso HD, Jackson EA, Buring JE. Development of predictive models for long-term cardiovascular risk associated with systolic and diastolic blood pressure. Hypertension 2002; 39: 105-110.
    • (2002) Hypertension , vol.39 , pp. 105-110
    • Glynn, R.J.1    L'italien, G.J.2    Sesso, H.D.3    Jackson, E.A.4    Buring, J.E.5
  • 22
    • 0034916227 scopus 로고    scopus 로고
    • Association between blood pressure level and the risk of myocardial infarction, stroke, and total mortality: The cardiovascular health study
    • Psaty BM, Furberg CD, Kuller LH, Cushman M, Savage PJ, Levine D et al. Association between blood pressure level and the risk of myocardial infarction, stroke, and total mortality: the cardiovascular health study. Arch Intern Med 2001; 161: 1183-1192.
    • (2001) Arch Intern Med , vol.161 , pp. 1183-1192
    • Psaty, B.M.1    Furberg, C.D.2    Kuller, L.H.3    Cushman, M.4    Savage, P.J.5    Levine, D.6
  • 24
    • 84865682640 scopus 로고    scopus 로고
    • Rethinking the association of high blood pressure with mortality in elderly adults: The impact of frailty
    • Odden MC, Peralta CA, Haan MN, Covinsky KE. Rethinking the association of high blood pressure with mortality in elderly adults: the impact of frailty. Arch Intern Med 2012; 172: 1162-1168.
    • (2012) Arch Intern Med , vol.172 , pp. 1162-1168
    • Odden, M.C.1    Peralta, C.A.2    Haan, M.N.3    Covinsky, K.E.4
  • 25
    • 33745295923 scopus 로고    scopus 로고
    • Dogma disputed: Can aggressively lowering blood pressure in hypertensive patients with coronary artery disease be dangerous?
    • Messerli FH, Mancia G, Conti CR, Hewkin AC, Kupfer S, Champion A et al. Dogma disputed: can aggressively lowering blood pressure in hypertensive patients with coronary artery disease be dangerous? Ann Intern Med 2006; 144: 884-893.
    • (2006) Ann Intern Med , vol.144 , pp. 884-893
    • Messerli, F.H.1    Mancia, G.2    Conti, C.R.3    Hewkin, A.C.4    Kupfer, S.5    Champion, A.6
  • 26
    • 84856021234 scopus 로고    scopus 로고
    • Low DBP may not be an independent risk for cardiovascular death in revascularized coronary artery disease patients
    • Kai H, Ueno T, Kimura T, Adachi H, Furukawa Y, Kita T et al. CREDO-Kyoto Investigators. Low DBP may not be an independent risk for cardiovascular death in revascularized coronary artery disease patients. J Hypertens 2011; 29: 1889-1896.
    • (2011) J Hypertens , vol.29 , pp. 1889-1896
    • Kai, H.1    Ueno, T.2    Kimura, T.3    Adachi, H.4    Furukawa, Y.5    Kita, T.6
  • 27
    • 79956341653 scopus 로고    scopus 로고
    • Limitations of analyses based on achieved blood pressure: Lessons from the African American study of kidney disease and hypertension trial
    • Davis EM, Appel LJ, Wang X, Greene T, Astor BC, Rahman M et al. African American Study of Kidney Disease and Hypertension Research Collaborative Group. Limitations of analyses based on achieved blood pressure: lessons from the African American study of kidney disease and hypertension trial. Hypertension 2011; 57: 1061-1068.
    • (2011) Hypertension , vol.57 , pp. 1061-1068
    • Davis, E.M.1    Appel, L.J.2    Wang, X.3    Greene, T.4    Astor, B.C.5    Rahman, M.6
  • 28
    • 0037133549 scopus 로고    scopus 로고
    • J-shaped relationship between blood pressure and mortality in hypertensive patients: New insights from a meta-analysis of individual-patient data
    • Boutitie F, Gueyffier F, Pocock S, Fagard R, Boissel JP. J-shaped relationship between blood pressure and mortality in hypertensive patients: new insights from a meta-analysis of individual-patient data. Ann Intern Med 2002; 136: 438-448.
    • (2002) Ann Intern Med , vol.136 , pp. 438-448
    • Boutitie, F.1    Gueyffier, F.2    Pocock, S.3    Fagard, R.4    Boissel, J.P.5
  • 30
    • 4544374978 scopus 로고    scopus 로고
    • Blood pressure-lowering drugs: Essential therapy for some patients with normal blood pressure
    • Fuchs FD. Blood pressure-lowering drugs: essential therapy for some patients with normal blood pressure. Expert Rev Cardiovasc Ther 2004; 2: 771-775.
    • (2004) Expert Rev Cardiovasc Ther , vol.2 , pp. 771-775
    • Fuchs, F.D.1
  • 31
    • 0034700790 scopus 로고    scopus 로고
    • Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: Results of the HOPE study and MICRO-HOPE substudy
    • The Heart Outcomes Prevention Evaluation Study Investigators.
    • The Heart Outcomes Prevention Evaluation Study Investigators. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Lancet 2000; 355: 253-259.
    • (2000) Lancet , vol.355 , pp. 253-259
  • 32
    • 0034688194 scopus 로고    scopus 로고
    • Effects of an angiotensin-convertingenzyme inhibitor, ramipril, on cardiovascular events in high-risk patients
    • Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G. The Heart Outcomes Prevention Evaluation Study Investigators. Effects of an angiotensin-convertingenzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med 2000; 342: 145-153.
    • (2000) N Engl J Med , vol.342 , pp. 145-153
    • Yusuf, S.1    Sleight, P.2    Pogue, J.3    Bosch, J.4    Davies, R.5    Dagenais, G.6
  • 33
    • 0042330455 scopus 로고    scopus 로고
    • Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: Randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study)
    • Fox KM. EURopean trial on reduction of cardiac events with Perindopril in stable coronary Artery disease Investigators. Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study). Lancet 2003; 362: 782-788.
    • (2003) Lancet , vol.362 , pp. 782-788
    • Fox, K.M.1
  • 34
    • 0035968623 scopus 로고    scopus 로고
    • Randomised trial of a perindopril-based bloodpressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack
    • PROGRESS Collaborative Group.
    • PROGRESS Collaborative Group. Randomised trial of a perindopril-based bloodpressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack. Lancet 2001; 358: 1033-1041.
    • (2001) Lancet , vol.358 , pp. 1033-1041
  • 35
    • 0026785561 scopus 로고
    • Effect of enalapril on mortality and development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions
    • The SOLVD investigators.
    • The SOLVD investigators. Effect of enalapril on mortality and development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Eng J Med 1992; 327: 685-691.
    • (1992) N Eng J Med , vol.327 , pp. 685-691
  • 36
    • 4544263729 scopus 로고
    • Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure
    • The SOLVD investigators.
    • The SOLVD investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Eng J Med 1991; 325: 669-677.
    • (1991) N Eng J Med , vol.325 , pp. 669-677
  • 37
    • 0026786643 scopus 로고
    • Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: Results of the Survival and Ventricular Enlargement Trial
    • Pfeffer MA, Braunwald E, Moye LA, Basta L, Brown Jr EJ, Cuddy TE et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: results of the Survival and Ventricular Enlargement Trial. The SAVE Investigators. N Eng J Med 1992; 327: 669-677.
    • (1992) N Eng J Med , vol.327 , pp. 669-677
    • Pfeffer, M.A.1    Braunwald, E.2    Moye, L.A.3    Basta, L.4    Brown Jr., E.J.5    Cuddy, T.E.6
  • 38
    • 79952213953 scopus 로고    scopus 로고
    • Antihypertensive treatment and secondary prevention of cardiovascular disease events among persons without hypertension: A meta-analysis
    • Thompson AM, Hu T, Eshelbrenner CL, Reynolds K, He J, Bazzano LA. Antihypertensive treatment and secondary prevention of cardiovascular disease events among persons without hypertension: a meta-analysis. JAMA 2011; 305: 913-922.
    • (2011) JAMA , vol.305 , pp. 913-922
    • Thompson, A.M.1    Hu, T.2    Eshelbrenner, C.L.3    Reynolds, K.4    He, J.5    Bazzano, L.A.6
  • 39
    • 79952197520 scopus 로고    scopus 로고
    • Prevention of hypertension in patients with pre-hypertension: Protocol for the PREVER-prevention trial
    • Fuchs FD, Fuchs SC, Moreira LB, Gus M, No brega AC, Poli-de-Figueiredo CE et al. Prevention of hypertension in patients with pre-hypertension: protocol for the PREVER-prevention trial. Trials 2011; 12: 65.
    • (2011) Trials , vol.12 , pp. 65
    • Fuchs, F.D.1    Fuchs, S.C.2    Moreira, L.B.3    Gus, M.4    No Brega, A.C.5    Poli-De-Figueiredo, C.E.6
  • 40
    • 85019316271 scopus 로고
    • Effects of enalapril on mortality in severe congestive heart failure
    • The CONSENSUS Trial Study Group.
    • The CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure. N Eng J Med 1987; 316: 1429-1435.
    • (1987) N Eng J Med , vol.316 , pp. 1429-1435
  • 41
    • 79958769725 scopus 로고    scopus 로고
    • Effects of intensive blood pressure reduction on myocardial infarction and stroke in diabetes: A meta-analysis in 73,913 patients
    • Reboldi G, Gentile G, Angeli F, Ambrosio G, Mancia G, Verdecchia P. Effects of intensive blood pressure reduction on myocardial infarction and stroke in diabetes: a meta-analysis in 73,913 patients. J Hypertens 2011; 29: 1253-1269.
    • (2011) J Hypertens , vol.29 , pp. 1253-1269
    • Reboldi, G.1    Gentile, G.2    Angeli, F.3    Ambrosio, G.4    Mancia, G.5    Verdecchia, P.6
  • 42
    • 84867144380 scopus 로고    scopus 로고
    • Intensive and standard blood pressure targets in patients with type 2 diabetes mellitus: Systematic review and meta-analysis
    • McBrien K, Rabi DM, Campbell N, Barnieh L, Clement F, Hemmelgarn BR et al. Intensive and standard blood pressure targets in patients with type 2 diabetes mellitus: systematic review and meta-analysis. Arch Intern Med 2012; 172: 1296-1303.
    • (2012) Arch Intern Med , vol.172 , pp. 1296-1303
    • McBrien, K.1    Rabi, D.M.2    Campbell, N.3    Barnieh, L.4    Clement, F.5    Hemmelgarn, B.R.6
  • 43
    • 82355175158 scopus 로고    scopus 로고
    • AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: A guideline from the american heart association and american college of cardiology foundation
    • Smith Jr SC, Benjamin EJ, Bonow RO, Braun LT, Creager MA, Franklin BA et al. World Heart Federation and the Preventive Cardiovascular Nurses Association. AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients with Coronary and other Atherosclerotic Vascular Disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation. Circulation 2011; 124: 2458-2473.
    • (2011) Circulation , vol.124 , pp. 2458-2473
    • Smith Jr., S.C.1    Benjamin, E.J.2    Bonow, R.O.3    Braun, L.T.4    Creager, M.A.5    Franklin, B.A.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.